p2

Cambridge Healthtech Institute’s Inaugural

Gene Therapy Analytics and Manufacturing

January 21-22, 2020

Part of the Cell & Gene Therapies pipeline

 

Cambridge Healthtech Institute’s Inaugural Gene Therapy Analytics and Manufacturing conference will take an in-depth look at the challenges facing the formulation, characterization, analysis and scale up of gene therapies. The conference will examine critical challenges facing the analysis, characterization, quality control and bioproduction process development and scale-up, of viral vector-based gene therapies such as AAV, lentivirus and retrovirus.  We are seeking cutting edge research findings and unpublished data to be featured at this forum.

 

Coverage will include, but is not limited to:

  • Development, translational and manufacturing challenges of gene therapy:
    • Lentiviral production, AAV production
    • Next-generation processes
    • Bioreactors and raw material safety
  • Analytics and characterization:
    • CMC and characterization requirements and tools
    • Analytical tools, methods and characterization
    • Aggregation and stability testing
    • Formulation design and development, stability and delivery
  • Gene editing and delivery:
    • Gene editing/CRISPR techniques in gene therapy
    • Viral and non-viral delivery systems
    • Nanoparticles      

 

* The program is subject to change without notice, due to unforeseen reason.







2020 Conferences & Training Seminars